Bowman (BWMN) Insider Notice: 10,000 Shares to Be Sold on NASDAQ
Rhea-AI Filing Summary
Bowman Consulting Group Ltd. (BWMN) filed a Form 144 notifying the proposed sale of 10,000 common shares held at Fidelity Brokerage Services with an aggregate market value of $433,040.76. The filing states these shares were acquired on 05/11/2024 through restricted stock vesting as compensation and that the proposed sale date is 09/23/2025 on the NASDAQ. The filing reports 17,250,737 shares outstanding for the company and indicates there were no securities sold by the reporting person in the past three months. The filer certifies under penalty of law that no undisclosed material adverse information is known.
Positive
- Full compliance with Rule 144 disclosure requirements including acquisition details, broker, planned sale date, and aggregate market value
- Transparency shown by attestation of no known undisclosed material adverse information and reporting no prior sales in the past three months
Negative
- Insider sale of 10,000 shares could be perceived negatively by some investors despite its small size relative to outstanding shares
Insights
TL;DR Routine insider sale notice: 10,000 vested shares (~0.058% of outstanding) proposed for sale, disclosed under Rule 144.
The filing documents a standard Rule 144 notice for shares received through restricted stock vesting on 05/11/2024 and designated for sale on 09/23/2025 via Fidelity Brokerage Services. The aggregate market value is stated as $433,040.76 and the company’s outstanding share count is 17,250,737, making the block a small fraction of outstanding equity. No sales in the prior three months are reported, which suggests this filing is the first recent disposition by the reporting person. From a market-impact perspective, the amount is immaterial relative to total shares outstanding.
TL;DR Disclosure aligns with compliance expectations; filing affirms no known undisclosed material adverse information.
The notice follows required disclosure protocols for director/officer or other affiliate sales under Rule 144 by identifying acquisition date, nature of acquisition as compensation, and the planned broker and exchange. The signer’s attestation that they are unaware of undisclosed material adverse information is standard and required by the form. This filing enhances transparency but does not by itself signal governance change or material corporate event.